111In-DOTA-DPhe1-Tyr3-octreotide, 111In-DOTA-lanreotide and 67Ga citrate scintigraphy for visualisation of extranodal marginal zone B-cell lymphoma of the MALT type: A comparative study

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 30, Issue 8, 2003, Pages 1087-1095

  Li, Shuren ^a   Kurtaran, Amir ^a   Li, Mei ^a   Traub Weidinger, Tatjana ^a   Kienast, Oskar ^a   Schima, Wolfgang ^a   Angelberger, Peter ^c   Virgolini, Irene ^b   Raderer, Markus ^a   Dudczak, Robert ^a,b  

^a UNIVERSITY OF VIENNA   (Austria)

^b Ludwig Boltzman Inst for Nucl Med   (Austria)

^c NONE

Author keywords

Gallium scintigraphy; MALT type lymphoma; Somatostatin receptor scintigraphy

Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID ANGIOPEPTIN IN 111; 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID OCTREOTIDE[1 DEXTRO PHENYLALANINE 3 TYROSINE] IN 111; GALLIUM CITRATE GA 67; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; (DOTA(0) PHE(1) TYR(3))OCTREOTIDE; (DOTA(0)-PHE(1)-TYR(3))OCTREOTIDE; CITRIC ACID; CYCLOPEPTIDE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; GALLIUM; GALLIUM CITRATE; HETEROCYCLIC COMPOUND; INDIUM; INDIUM 111 DOTA LANREOTIDE; INDIUM 111-DOTA-LANREOTIDE; OCTREOTIDE;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; BONE MARROW BIOPSY; CANCER SCINTISCANNING; CLINICAL ARTICLE; COLONOSCOPY; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENDOSCOPY; FEMALE; GASTROSCOPY; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; MALE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; OPHTHALMOSCOPY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; CLINICAL TRIAL; LABORATORY DIAGNOSIS; MIDDLE AGED; PATHOLOGY; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY;

ADULT; AGED; AGED, 80 AND OVER; CITRATES; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FEMALE; GALLIUM; HETEROCYCLIC COMPOUNDS; HUMANS; INDIUM RADIOISOTOPES; LYMPHOMA, MUCOSA-ASSOCIATED LYMPHOID TISSUE; MALE; MIDDLE AGED; OCTREOTIDE; PEPTIDES, CYCLIC; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 0041735279     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-003-1206-1     Document Type: Article

References (25)

1. Isaacson PG, Wright DH. Malignant lymphoma of mucosal associated lymphoid tissue: a distinctive type of B cell lymphoma. Cancer 1983; 52:1410-1416.
2. Isaacson PG, Norton AJ. Mucosa associated lymphoid tissue (MALT) and the MALT-lymphoma concept. In: Isaacson PG, Norton AJ, eds. Extranodal lymphomas. Edinburgh: Churchill-Livingstone; 1994:5-14.
3. Thieblemont C, Bastion Y, Berger F, et al. Mucosa-associated lymphoid tissue gastrointestinal and nongastrointestinal lymphoma behavior: analysis of 108 patients. J Clin Oncol 1997; 15:1624-1630.
4. Taal BG, Burgers JM, van Heerde P, et al. The clinical spectrum and treatment of primary non-Hodgkin's lymphoma of the stomach. Ann Oncol 1993; 4:839-846.
5. Raderer M, Vorbeck F, Formanek M, et al. Importance of extensive staging in patients with mucosa-associated lymphoid tissue (MALT)-type lymphoma. Br J Cancer 2000; 83:454-457.
6. van den Anker-Lugdenburg PJ, Lowenberg B, Lamberts SW, et al. The relevance of somatostatin receptor expression in malignant lymphomas. Metabolism 1996; 45:96-97.
7. Kwekkeboom DJ, Krenning EP. Somatostatin receptor imaging. Semin Nucl Med 2002; 32:84-91.
8. 3-octreotide a promising somatostatin analogue for radionuclide therapy. Eur J Nucl Med 1997; 24:368-371.
9. Breeman WA, de Jong M, Kwekkeboom DJ, et al. Somatostatin receptor-mediated imaging and therapy: basic science, current knowledge, limitations and future perspectives. Eur J Nucl Med 2001; 28:1421-1429.
10. Raderer M, Valencak J, Pfeffel F, et al. Somatostatin receptor expression in primary gastric versus nongastric extranodal B-cell lymphoma of mucosa-associated lymphoid tissue type. J Natl Cancer Inst 1999; 91:716-718.
11. Raderer M, Traub T, Formanek M, et al. Somatostatin-receptor scintigraphy for staging and follow-up of patients with extraintestinal marginal zone B-cell lymphoma of the mucosa associated lymphoid tissue (MALT)-type. Br J Cancer 2001; 85:1462-1466.
12. Lugtenburg PJ, Lowenberg B, Valkema R, et al. Somatostatin receptor scintigraphy in the initial staging of low-grade non-Hodgkin's lymphomas. J Nucl Med 2001; 42:222-229.
13. Gallamini A, Biggi A, Fruttero A, et al. Revisiting the prognostic role of gallium scintigraphy in low-grade non-Hodgkin's lymphoma. Eur J Nucl Med 1997; 24:1499-1506.
14. Delcambre C, Reman O, Henry-Amar M, et al. Clinical relevance of gallium-67 scintigraphy in lymphoma before and after therapy. Eur J Nucl Med 2000; 27:176-184.
15. Fukumoto M, Kurohara A, Akagi N, et al. Ga-67 visualization of the coexistence of two mucosa-associated lymphoid tissue (MALT) lymphomas in the thyroid and stomach. Clin Nucl Med 1998; 23:484.
16. Ben-Haim S, Bar-Shalom R, Israel O, et al. Utility of gallium-67 scintigraphy in low-grade non-Hodgkin's lymphoma. J Clin Oncol 1996; 14:1936-1942.
17. Rohatiner A, d'Amore F, Coiffier B, et al. Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Ann Oncol 1994; 5:397-400.
18. Smith-Jones PM, Bischof C, Leimer M, et al. DOTA-lanreotide: a novel somatostatin analog for tumor diagnosis and therapy. Endocrinology 1999; 140:5136-5148.
19. Virgolini I, Patri P, Novotny C, et al. Comparative somatostatin receptor scintigraphy using In-111-DOTA-lanreotide and In-111-DOTA-Tyr3-octreotide versus F-18-FDG-PET for evaluation of somatostatin receptor-mediated radionuclide therapy. Ann Oncol 2001; 12 (Suppl 2):S41-S45.
20. Pileri SA, Milani M, Fraternali-Orcioni G, et al. From the R.E.A.L. Classification to the upcoming WHO scheme: a step toward universal categorization of lymphoma entities? Ann Oncol 1998; 9:607-612.
21. Hoffmann M, Kletter K, Diemling M, et al. Positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D-glucose (F18-FDG) does not visualize extranodal B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT)-type. Ann Oncol 1999; 10:1185-1189.
22. Stomper PC, Cholewinski SP, Park J, et al. Abdominal staging of thoracic Hodgkin disease: CT-lymphangiography-Ga-67 scanning correlation. Radiology 1993; 187:381-386.
23. Reubi JC, Schar JC, Waser B, et al. Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use. Eur J Nucl Med 2000; 27:273-282.
24. Virgolini I, Traub T, Novotny C, et al. Experience with indium-111 and yttrium-90-labeled somatostatin analogs. Curr Pharm Des 2002; 8:1781-1807.
25. Ferreri AJ, Ponzoni M, Cordio S, et al. Low sensitivity of computed tomography in the staging of gastric lymphomas of mucosa-associated lymphoid tissue: impact on prospective trials and ordinary clinical practice. Am J Clin Oncol 1998;21:614-616.